article thumbnail

‘Proactive’ vaccine can protect against unknown future coronaviruses

Drug Discovery World

Researchers have developed a new vaccine technology that can provide protection against a broad range of coronaviruses with potential for future disease outbreaks – including ones we don’t know about yet. By training the immune system to attack these regions, it gives protection against other coronaviruses not represented in the vaccine.

Vaccine 130
article thumbnail

One coronavirus vaccine may protect against other coronaviruse

The Pharma Data

Northwestern Medicine scientists have shown for the first time that coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses. The findings build a rationale for universal coronavirus vaccines that could prove useful in the face of future epidemics.

Vaccine 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PFIZER ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER FRANK D’AMELIO

The Pharma Data

Mike McDermott has been with Pfizer for 18 times having started with the Company in 2003 as head of also Wyeth’s Biotech Manufacturing Operations at its Pearl River, New York point. As a result of his sweats, Pfizer expects to achieve the thing of producing 3 billion boluses of COVID-19 vaccines in 2021 and 4 billion boluses in 2022.

Vaccine 52
article thumbnail

Women in Stem with Andrea Pfeifer

Drug Target Review

Then I was approached to co-found AC Immune in 2003. Food and Drug Administration for our Alzheimer’s vaccine candidate, ACI-24.060. COVID-19 has shown the revolutionary impact of vaccines. My family and friends said I was crazy to take this step. People with Down syndrome are an important addition to the clinical study.

Disease 95
article thumbnail

Africa to be declared free of wild polio in 'milestone'

The Pharma Data

There is no cure but the polio vaccine protects children for life. A polio vaccine was developed in 1952. Now only the vaccine-derived polio virus remains in Africa. This is a rare form of the virus that mutates from the oral polio vaccine and can then spread to under-immunised communities. Image copyright. Getty Images.

Vaccine 52
article thumbnail

Mike Nally to Leave Merck; Frank Clyburn to Lead All Merck Human Health

The Pharma Data

Michael Nally has served as chief marketing officer for Human Health since January 2019, following three years leading Merck’s global vaccines business. Nally has been at Merck since 2003 and served in a number of roles with increasing responsibilities including the managing director of the company’s U.K.,

article thumbnail

U.S. FDA ACCEPTS FOR PRIORITY REVIEW

The Pharma Data

FDA ACCEPTS FOR PRIORITY REVIEW PFIZER’S APPLICATION FOR TICOVAC (TICK-BORNE ENCEPHALITIS VACCINE). If approved, the vaccine may help reduce the risk of TBE for people traveling to endemic areas, potentially including military personnel serving in these locations. 1,2 If approved, TicoVac would be the first vaccine in the U.S.

FDA 52